animal health

EuroAPI Secures €130-150 Million Animal Health Contract

EuroAPI has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company.

MSD Animal Health to Acquire Elanco’s Aqua Business

MSD Animal Health, a division of Merck & Co., announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for €1.2 billion ($1.3 billion) in cash. The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory authorities and other customary closing conditions.

Bayer to Sell Animal Health to Elanco

Bayer and Elanco Animal Health Link-up?

Private Equity Eyes Bayer’s Animal Health

DSM and Amyris Expand Cooperation

CordenPharma Expands Manufacturing Capacities for Veterinary Drug Products

Sanofi and Boehringer Complete Swap

Boehringer to Sell Pet Vaccines to Lilly

Sanofi and Boehringer Ingelheim Finalize Swap

Bayer May Consider Selling Animal Health

After Pharma’s Patent Cliff

Will Consolidation Force Bayer’s Hand?

Sanofi and Boehringer Ingelheim Agree Asset Swap

Bayer Still Eyeing IPO for MaterialScience

Olivier Brandicourt to leave Bayer and become CEO of Sanofi

XL-protein Licenses Technology to MSD

CPhI Worldwide Announces International Advisory Board

Novartis and Lilly Clinch Animal Health Deal

EU States Deadlocked on Genetically Modified Maize Approvals

Pfizer to Spin Off Zoetis Stake to Shareholders

Bayer HealthCare Integrates Animal Health Acquisition

Strong Pet Product Sales Help Zoetis Top Estimates

Zoetis IPO Prices at $26; Largest US Deal Since Facebook

The Future of Fine Chemical Production

Pfizer Beats Forecasts, Helped by Cost Cuts

Pfizer Plans Animal Health IPO

Bayer Sounds Out Debt Market with Eye On Deals